Definitive Healthcare to present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology Conference
Definitive Healthcare (Nasdaq: DH) will present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology...
Definitive Healthcare wins gold in the 2022 Stevie Awards for Great Employers
Definitive Healthcare has been named the winner of a Gold Stevie Award® in the seventh annual Stevie Awards for Great Employers.
Definitive Healthcare wins 2022 Medigy HITMC Award for Video of the Year
Definitive Healthcare was named a 2022 Medigy HITMC Award Winner for a video celebrating the launch of its Latitude Reporting product.
Definitive Healthcare reports financial results for second quarter fiscal year 2022
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended June 30, 2022.
Definitive Healthcare to present at the Canaccord Genuity 42nd Annual Growth Conference
Definitive Healthcare (Nasdaq: DH) will present at the Canaccord Genuity 42nd Annual Conference on August 10, 2022.
Definitive Healthcare wins three Stevie® American Business Awards® for customer service
Definitive Healthcare was named a winner of three Stevie® Awards in the 20th Annual American Business Awards®.
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards.
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
Definitive Healthcare announced the general availability of Passport Express, the newest product in the Passport Analytics Suite.
Definitive Healthcare announces timing of its second quarter 2022 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) announced that its second quarter ended June 30, 2022 financial results will be released on Thursday, August 4...
